+Compare
EMBC
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
1.05B

EMBC Embecta Corp Forecast, Technical & Fundamental Analysis

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for EMBC with price predictions
07:00 PM EST Dec 05, 2023

EMBC's Stochastic Oscillator stays in overbought zone for 13 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for EMBC moved out of overbought territory on December 05, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 4 similar instances where the indicator moved out of overbought territory. In of the 4 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMBC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 14, 2023. You may want to consider a long position or call options on EMBC as a result. In of 35 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EMBC just turned positive on November 14, 2023. Looking at past instances where EMBC's MACD turned positive, the stock continued to rise in of 15 cases over the following month. The odds of a continued upward trend are .

EMBC moved above its 50-day moving average on November 14, 2023 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for EMBC crossed bullishly above the 50-day moving average on November 15, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 4 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EMBC advanced for three days, in of 90 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 36 cases where EMBC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.614) is normal, around the industry mean (25.240). P/E Ratio (15.033) is within average values for comparable stocks, (79.553). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.249). Dividend Yield (0.033) settles around the average of (0.019) among similar stocks. P/S Ratio (0.945) is also within normal values, averaging (44.190).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. EMBC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EMBC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NASDAQ:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NASDAQ:MDT), Boston Scientific Corp (NASDAQ:BSX), Edwards Lifesciences Corp (NASDAQ:EW), IQVIA Holdings (NASDAQ:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.41B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 2%. For the same Industry, the average monthly price growth was 10%, and the average quarterly price growth was -11%. SERA experienced the highest price growth at 191%, while IMMVF experienced the biggest fall at -95%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -0%. For the same stocks of the Industry, the average monthly volume growth was 10% and the average quarterly volume growth was 41%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 55
SMR Rating: 84
Profit Risk Rating: 87
Seasonality Score: 19 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

EMBC is expected to report earnings to fall 19.49% to 47 cents per share on February 13

Embecta Corp EMBC Stock Earnings Reports
Q4'23
Est.
$0.47
Q3'23
Beat
by $0.19
Q2'23
Beat
by $0.23
Q1'23
Beat
by $0.27
Q4'22
Beat
by $0.25
The last earnings report on November 21 showed earnings per share of 58 cents, beating the estimate of 40 cents. With 233.38K shares outstanding, the current market capitalization sits at 1.05B.
A.I.Advisor
published Dividends

EMBC is expected to pay dividends on December 15, 2023

Embecta Corp EMBC Stock Dividends
A dividend of $0.15 per share will be paid with a record date of December 15, 2023, and an ex-dividend date of December 01, 2023. The last dividend of $0.15 was paid on September 13. Read more...
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
300 Kimball Drive
Phone
+1 201 847-6880
Employees
1900
Web
https://www.embecta.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FWATX13.000.02
+0.15%
Fidelity Advisor® Multi-Asset Income A
NAWGX40.03N/A
N/A
Voya Global High Dividend Low Vol A
MMQTX8.24N/A
N/A
MassMutual Small Cap Val Eq R3
JGTUX30.90-0.20
-0.64%
JPMorgan Growth Advantage R4
JGLTX15.08-0.12
-0.79%
Janus Henderson VIT Glb Tech&Innvt Instl

EMBC and

Correlation & Price change

A.I.dvisor indicates that over the last year, EMBC has been loosely correlated with KIDS. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if EMBC jumps, then KIDS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMBC
1D Price
Change %
EMBC100%
-2.38%
KIDS - EMBC
33%
Loosely correlated
-0.44%
RVTY - EMBC
33%
Loosely correlated
+1.44%
INMD - EMBC
32%
Poorly correlated
-9.99%
IDXX - EMBC
32%
Poorly correlated
+0.50%
NEOG - EMBC
31%
Poorly correlated
+1.81%
More

Groups containing EMBC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMBC
1D Price
Change %
EMBC100%
-2.38%
Medical Specialties
(undefined stocks)
38%
Loosely correlated
+0.53%
Medical Specialties
(undefined stocks)
38%
Loosely correlated
+0.54%